fluocinolone acetonide effective in diabetic macular edema
Links shared publicly online about this topic.
- 37total visits
fluocinolone acetonide effective in diabetic macular edema
View full resource at eyedocnews.com
Tags: Edema, Diabetes, Cataract, Ophthalmology
Most Recently Shared on August 29, 2011 at 10:51 am By:
Discuss: Fluocinolone Acetonide Implant Effective In Diabetic Macular Edema: Ophthalmology: The fluocinolone ace... http://t.co/0StA1Za
FAME: Steroid implant an efficacious treatment option for diabetic macular edema
endocrinetoday.com — “Twenty-four month results for two phase 3 clinical trials suggested that low- and high-dose fluocinolone acetonide implants may be efficacious i” View full resource at endocrinetoday.com
Most Recently Shared on August 1, 2011 at 9:09 pm By:
FAME: Steroid implant an efficacious treatment option for diabetic macular edema http://bit.ly/qbWz2H
pSivida Announces Resubmission of New Drug Application for Iluvien
drugs.com — “Iluvien (fluocinolone acetonide) is a new drug formulation in development for the treatment of Diabetic Macular Edema. Iluvien information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 13, 2011 at 11:06 pm By:
Drugs and Devices OW OW Health
pSivida Announces Resubmission of New Drug Application for Iluvien: WATERTOWN, Mass.--(BUSINESS WIRE)--May... http://bit.ly/m19oHW #drug
Phase 3 Study of Iluvien for Diabetic Macular Edema - MPR
empr.com — “pSivida Corp. announced new data from its Phase 3 study of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema.” View full resource at empr.com
Most Recently Shared on May 3, 2011 at 4:06 pm By:
MPR News: Phase 3 Study of Iluvien for Diabetic Macular Edema: pSivida Corp. announced new data from its Phase 3... http://bit.ly/iisxtm
Phase 3 Study of Iluvien for Diabetic Macular Edema - ONA
oncologynurseadvisor.com — “pSivida Corp. announced new data from its Phase 3 study of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 3, 2011 at 3:59 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Phase 3 Study of Iluvien for Diabetic Macular Edema http://goo.gl/fb/e9mrq
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - ONA
oncologynurseadvisor.com — “pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 4, 2011 at 6:36 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) http://goo.gl/fb/ZLLpF
Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME) - MPR
empr.com — “pSivida Corporation announced top-line readout results from two Phase 3 studies of Iluvien (sustained release fluocinolone acetonide insert) for the treatment of diabetic macular edema (DME).” View full resource at empr.com
Most Recently Shared on February 4, 2011 at 6:25 pm By:
MPR News: Phase 3 studies of Iluvien for the treatment of diabetic macular edema (DME): pSivida Corporation anno... http://bit.ly/gDuoFl
FDA Issues Complete Response Letter Regarding New Drug Application for Iluvien
drugs.com — “Iluvien (fluocinolone acetonide) is a new drug formulation in development for the treatment of Diabetic Macular Edema. Iluvien information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on January 9, 2011 at 12:10 am By:
Drugs and Devices OW OW Health
FDA Issues Complete Response Letter Regarding New Drug Application for Iluvien: WATERTOWN, Mass.--(BUSINES... http://bit.ly/eiHec9 #drug
Iluvien For Diabetic Macular Edema Turned Down By FDA
medicalnewstoday.com — “Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration)” View full resource at medicalnewstoday.com
Most Recently Shared on December 24, 2010 at 10:09 pm By:
Iluvien For Diabetic Macular Edema Turned Down By FDA http://bit.ly/ijVqiA
Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review
medicalnewstoday.com — “Iluvien(R) (fluocinolone acetonide intravitreal insert), an investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide for DME (diabetic macular e” View full resource at medicalnewstoday.com
Most Recently Shared on August 31, 2010 at 6:33 pm By:
Scott Strumello Patient Expert
Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review: http://bit.ly/c1lNuz
Advertisement
